
Hyperthermia Therapy Market Report 2026
Global Outlook – By Therapy Type (Local Hyperthermia Therapy, Regional Hyperthermia Therapy, Whole Body Hyperthermia Therapy), By Device (External Surface Devices, Interstitial Or Intracavitary Devices, Deep Tissue Applicators, Monitoring And Thermometry Systems), By Modality (Radiofrequency Hyperthermia, Microwave Hyperthermia, Ultrasound Hyperthermia), By Application (Oncology Treatment, Radiosensitization, Chemosensitization, Palliative Care), By End User (Hospitals, Cancer Treatment Centers, Specialty Clinics, Research Institutes, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Hyperthermia Therapy Market Report 2026 Market Overview
• Hyperthermia Therapy Market Report 2026 market size has reached to $0.25 billion in 2025 • Expected to grow to $0.38 billion in 2030 at a compound annual growth rate (CAGR) of 8.7% • Growth Driver: Surge In Cancer Incidence Fueling The Growth Of The Market Due To The Rising Demand For Advanced And Adjunctive Cancer Treatment • Market Trend: Advancements In Magnetic Nanoparticle Hyperthermia Supporting Precision Oncology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Hyperthermia Therapy Market?
Hyperthermia therapy is a medical treatment approach that uses controlled heat application to raise the temperature of targeted tissues for therapeutic purposes. It is designed to enhance biological responses within the body by improving cellular activity, increasing blood flow, and supporting the effectiveness of certain therapeutic interventions. Hyperthermia therapy involves the use of specialized technologies to deliver precise and regulated heat to specific areas while minimizing damage to surrounding healthy tissues. The main therapy types of hyperthermia therapy include local hyperthermia therapy, regional hyperthermia therapy, and whole body hyperthermia therapy. Local hyperthermia therapy refers to targeted heating techniques that increase the temperature of specific tumor sites or affected tissues to enhance therapeutic outcomes while minimizing damage to surrounding healthy tissues. These therapies are delivered using devices such as external surface devices, interstitial or intracavitary devices, deep tissue applicators, and monitoring and thermometry systems and various modalities involved are radiofrequency hyperthermia, microwave hyperthermia, and ultrasound hyperthermia. They find applications in oncology treatment, radiosensitization, chemosensitization, and palliative care and these therapies are utilized by end users such as hospitals, cancer treatment centers, specialty clinics, research institutes, and others.
What Is The Hyperthermia Therapy Market Size and Share 2026?
The hyperthermia therapy market size has grown strongly in recent years. It will grow from $0.25 billion in 2025 to $0.27 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to growing prevalence of cancer cases, increasing adoption of hyperthermia as an adjunct cancer therapy, rising demand for minimally invasive treatment options, expanding oncology infrastructure, increasing clinical research activities for thermal therapy applications.What Is The Hyperthermia Therapy Market Growth Forecast?
The hyperthermia therapy market size is expected to see strong growth in the next few years. It will grow to $0.38 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing integration of precision medicine approaches, rising demand for personalized oncology treatments, growing adoption of advanced thermometry systems, expanding use of combination treatment strategies, increasing investment in next-generation hyperthermia devices. Major trends in the forecast period include increasing adoption of advanced heat delivery technologies, growing development of personalized hyperthermia treatment protocols, rising integration of real-time temperature monitoring systems, expansion of combination therapies with radiation and chemotherapy, increasing demand for non-invasive thermal treatment approaches.
Global Hyperthermia Therapy Market Segmentation
1) By Therapy Type: Local Hyperthermia Therapy, Regional Hyperthermia Therapy, Whole Body Hyperthermia Therapy 2) By Device: External Surface Devices, Interstitial Or Intracavitary Devices, Deep Tissue Applicators, Monitoring And Thermometry Systems 3) By Modality: Radiofrequency Hyperthermia, Microwave Hyperthermia, Ultrasound Hyperthermia 4) By Application: Oncology Treatment, Radiosensitization, Chemosensitization, Palliative Care 5) By End User: Hospitals, Cancer Treatment Centers, Specialty Clinics, Research Institutes, Other End Users Subsegments: 1) By Local Hyperthermia Therapy: External Hyperthermia, Interstitial Hyperthermia, Intracavitary Hyperthermia 2) By Regional Hyperthermia Therapy: Deep Tissue Regional Hyperthermia, Regional Perfusion Hyperthermia, Hyperthermic Intraperitoneal Chemotherapy 3) By Whole Body Hyperthermia Therapy: Moderate Temperature Whole Body Hyperthermia, High Temperature Whole Body HyperthermiaWhat Is The Driver Of The Hyperthermia Therapy Market?
The increasing cancer incidence is expected to propel the growth of the hyperthermia therapy market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body, which can invade tissues and disrupt normal organ functions. The increasing cancer incidence is driven by the growing prevalence of risk factors such as aging populations, unhealthy lifestyles, and environmental exposures, which contribute to a higher number of cancer cases and increase the demand for advanced diagnostic and treatment solutions. The rising incidence of cancer is increasing demand for hyperthermia therapy, as it is used alongside chemotherapy and radiotherapy to improve treatment effectiveness and patient outcomes. For instance, in July 2026, according to the World Health Organization (WHO), a Switzerland-based UN agency, annual new cancer cases stood at 20.6 million in 2024 and are projected to rise to nearly 35 million by 2050, a nearly 70% increase. Therefore, increasing cancer incidence is expected to drive the growth of the hyperthermia therapy industry.Key Players In The Global Hyperthermia Therapy Market
Major companies operating in the hyperthermia therapy market report are Chongqing Haifu Medical Technology Co. Ltd., RanD Biotech S.r.l., Combat Medical Ltd., Pyrexar Medical Inc., Oncotherm Kft., Celsius42 GmbH, Elmedical Ltd., Thermofield, Shanghai Huayuan Electronic Co. Ltd., Dr. Sennewald Medizintechnik GmbH, Sensius B.V., Andromedic S.r.l., innoMedicus Ltd., ThermaSolutions Inc., Von Ardenne Institut GmbH, Gamida Ltd., Yamamoto Vinita Co. Ltd., Hydrosun Medizintechnik GmbH, Verthermia
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.

This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Global Hyperthermia Therapy Market Trends and Insights
Major companies operating in the hyperthermia therapy market are increasingly prioritizing magnetic nanoparticle-mediated hyperthermia systems to advance precision cancer treatment, improve therapeutic outcomes, and expand research into minimally invasive oncology solutions. Magnetic nanoparticle-mediated hyperthermia systems use magnetic nanoparticles activated by alternating magnetic fields to generate localized heat within tumors, enabling targeted cancer cell destruction while minimizing damage to surrounding healthy tissues and supporting combination therapies. For instance, in February 2026, Mayo Clinic, a US-based academic medical center, collaborated with New Phase Ltd., an Israel-based medical technology company, to install the first magnetic nanoparticle-mediated hyperthermia system for cancer research in the United States. The investigational system is designed to support research evaluating the safety, feasibility, and potential effectiveness of magnetic nanoparticle hyperthermia in cancer treatment. It enables targeted heat-based therapy and advances clinical research. The magnetic nanoparticle-mediated hyperthermia system supports the development of innovative cancer treatment approaches and accelerates the adoption of precision hyperthermia therapy.What Are Latest Mergers And Acquisitions In The Hyperthermia Therapy Market?
In October 2023, Andromedic, an Italy-based provider of capacitive hyperthermia devices, collaborated with Sensius to advance hyperthermia and thermotherapy in the Italian market. Through this partnership, Andromedic and Sensius aimed to advance the adoption of hyperthermia and thermotherapy in Italy by supporting clinical research, engaging oncology societies, and facilitating reimbursement pathways. Sensius is a Netherlands-based developer of precision hyperthermia therapy systems.
Regional Outlook
North America was the largest region in the hyperthermia therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Hyperthermia Therapy Market?
The hyperthermia therapy market consists of revenues earned by entities by providing services such as data management services, technical support services, and post-treatment follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperthermia therapy market also includes sales of radiofrequency hyperthermia systems, microwave hyperthermia systems, capacitive hyperthermia devices, and ultrasound hyperthermia systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.

This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
What Key Data and Analysis Are Included in the Hyperthermia Therapy Market Report 2026?
The hyperthermia therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hyperthermia therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Hyperthermia Therapy Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $0.27 billion |
| Revenue Forecast In 2030 | $0.38 billion |
| Growth Rate | CAGR of 8.7% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Therapy Type, Device, Modality, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Chongqing Haifu Medical Technology Co. Ltd., RanD Biotech S.r.l., Combat Medical Ltd., Pyrexar Medical Inc., Oncotherm Kft., Celsius42 GmbH, Elmedical Ltd., Thermofield, Shanghai Huayuan Electronic Co. Ltd., Dr. Sennewald Medizintechnik GmbH, Sensius B.V., Andromedic S.r.l., innoMedicus Ltd., ThermaSolutions Inc., Von Ardenne Institut GmbH, Gamida Ltd., Yamamoto Vinita Co. Ltd., Hydrosun Medizintechnik GmbH, Verthermia |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
